Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Free-Water Diffusion Tensor Imaging (DTI) Improves the Accuracy and Sensitivity of White Matter Analysis in Alzheimer’s Disease
Aging, Dementia, and Behavioral Neurology
P2 - Poster Session 2 (8:00 AM-9:00 AM)
10-010

Investigate differences in white matter (WM) integrity between Alzheimer’s and healthy subjects (HC) using diffusion tensor imaging (DTI) and free-water (FW)-DTI.

Alzheimer’s disease (AD) is a neurodegenerative disorder and the most common cause of dementia in older adults. DTI has been used in AD to assess WM integrity with metrics such as fractional anisotropy (FA), axial/radial diffusivities (AxD and RD), and mode of anisotropy (MA). However, DTI is susceptible to the effects of extracellular FW, which can be removed using an advanced FW-DTI model. Here, we compared these two DTI techniques for assessing WM integrity in AD. 

MRI-data were download from the OASIS-3 database; 30 HCs and 28 AD patients were included. DTI data were preprocessed using FSL. The diffusion tensor for both methods was fit using an in-house MATLAB script. FSL-Randomise tool was used to compare WM between groups using ANCOVA, with age and gender as covariates.

With both standard and FW-DTI, decreased FA consistent with neurodegeneration was found in AD, mainly in the corpus callosum and fornix. Widespread nonspecific increases in AxD and RD were observed with standard DTI; in contrast, AxD and RD were largely decreased with FW-DTI. Using FW-DTI, improved consistency was observed in both the spatial location of altered DTI metrics and in terms of the magnitude and direction of these alterations. With both standard and FW-DTI, increased MA coupled with increased FA in AD was found in the anterior thalamic radiation and cortical spinal tract, suggestive of a loss of crossing fibers. Higher FW was observed in AD compared to HC in several WM areas, indicative of AD-associated neurodegeneration.

The implementation of a FW correction algorithm for DTI improves the accuracy of derived DTI metrics and better reflects the underlying pathology of AD. FW-DTI metrics may provide novel insight into AD-related WM changes. 

Authors/Disclosures
Ryan R. Walsh, MD, PhD, FÂé¶¹´«Ã½Ó³»­ (Muhammad Ali Parkinson Center at Barrow Neurological Institute)
PRESENTER
Dr. Walsh has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Walsh has stock in Praxis Precision Medicines.
Maurizio Bergamino No disclosure on file
No disclosure on file